Ernexa Therapeutics Inc.
ERNA | NASDAQ
$3.92
-$0.04 (-1.01%)
Sep 22, 2026, 1:02 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 5.03M | 9.18M | 1.88M | 3.05M | 4.32M | 1.92M | 1.73M | 4.26M | 2.59M | 5.12M | 7.58M | 4.55M | 1.84M | 5.4M | 11.45M | 13.25M | 19.41M | 23.5M | 16.99M | 24.38M | 50.16M | 8.41M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.09M | 4.09M | n/a | 4.1M | n/a | 8K | 59K | 68K | 89K | 385K | 1M | 1M | n/a | n/a |
Other Long-Term Assets | 25K | 110K | 110K | 116K | 117K | 118K | 118K | 120K | 120K | 120K | 4.22M | 8.14M | 5.47M | 5.34M | 5.23M | 819K | 477K | 421K | 488K | 7.38M | 7.37M | 488.53K |
Receivables | 83K | 95K | 95K | 153K | 154K | 156K | 437K | 187K | 228K | 351K | 425K | 1.78M | 984K | 647K | 951K | 926K | 694K | 835K | 684K | 23.3K | 23.3K | 53.41K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 783K | 724K | 1.15M | 179K | 323K | 137K | 186K | 279K | 769K | 697K | 1.6M | 704K | 1.07M | 471K | n/a | n/a | n/a | n/a | n/a | 1.35M | 1.75M | 250.24K |
Total Current Assets | 5.89M | 10M | 3.13M | 3.38M | 4.79M | 2.21M | 2.35M | 4.73M | 3.58M | 6.16M | 9.6M | 7.03M | 3.89M | 6.52M | 13.68M | 15.85M | 21.93M | 25.14M | 18.77M | 25.76M | 51.94M | 8.71M |
Property-Plant & Equipment | 396K | 437K | 547K | 633K | 631K | 686K | 755K | 824K | 36.64M | 37.23M | 33.27M | 35.03M | 35.55M | 1.2M | 1.27M | 2.14M | 2.37M | 1.4M | 3.24M | 3.21M | 3.35M | 2.59M |
Goodwill & Intangibles | n/a | n/a | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 8.03M | 8.03M | 2.04M | 2.04M | 8.9M |
Total Long-Term Assets | 421K | 547K | 2.7M | 2.79M | 2.79M | 2.85M | 2.92M | 2.99M | 42.9M | 43.49M | 39.53M | 45.22M | 43.06M | 8.59M | 8.6M | 5.07M | 4.98M | 10.24M | 12.76M | 13.64M | 12.77M | 11.98M |
Total Assets | 6.32M | 10.54M | 5.83M | 6.17M | 7.58M | 5.06M | 5.27M | 7.72M | 46.49M | 49.66M | 49.13M | 52.25M | 46.95M | 15.11M | 22.28M | 20.93M | 26.9M | 35.38M | 31.53M | 39.39M | 64.71M | 20.7M |
Account Payables | 1.38M | 1.3M | 1.13M | 958K | 1.32M | 1.28M | 1.72M | 2.19M | 2.19M | 2.06M | 1.07M | 1.46M | 2.68M | 1.46M | 1.62M | 1.15M | 1.48M | 1.11M | 1.76M | 996.26K | 3.68M | 1.81M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 189K | 189K | 190K | 349K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 167K | 163K | 213K | n/a | n/a | 2.25M | 207K | 776K | 4.27M | 2.87M | n/a | 1.64M | 1.75M | 1.75M | 1.75M | n/a | n/a | n/a | n/a | 410K | 719.91K | 929.59K |
Other Current Liabilities | 2.77M | 1.49M | 1.76M | 151K | 274K | 5.35M | 12K | 6.66M | 2.81M | 2.44M | 109K | 4.9M | -976K | -1.54M | -322K | 4.35M | 3.04M | 682K | 903K | 617.66K | 985.23K | 572.08K |
Total Current Liabilities | 2.93M | 3.46M | 3.11M | 2.14M | 2.65M | 10.44M | 2.94M | 9.95M | 9.6M | 7.77M | 6.57M | 9.63M | 7.17M | 5.41M | 7.65M | 7.47M | 7.12M | 3.68M | 3.68M | 4.56M | 7.68M | 3.9M |
Long-Term Debt | 182K | n/a | n/a | n/a | n/a | n/a | n/a | 32.04M | 8.9M | 8.01M | 6.77M | 3.45M | 331K | 768K | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | 77.67K |
Other Long-Term Liabilities | 1K | 1K | 43K | 112K | 113K | 152K | 153K | 10.59M | 175K | 377K | 307K | 360K | 379K | 463K | 425K | 2.32M | 2.57M | 13.36M | 47K | 19.38M | 19.31M | 19.31M |
Total Long-Term Liabilities | 183K | 227K | 320K | 458K | 489K | 571K | 630K | 43.16M | 45.41M | 45.3M | 40.33M | 39.06M | 35.92M | 2.32M | 2.52M | 4.65M | 5.01M | 14.38M | 2.34M | 21.79M | 21.84M | 21.22M |
Total Liabilities | 3.12M | 3.68M | 3.43M | 2.6M | 3.14M | 11.01M | 3.57M | 53.11M | 55.01M | 53.07M | 46.9M | 48.69M | 43.09M | 7.73M | 10.17M | 12.11M | 12.12M | 18.07M | 6.02M | 26.35M | 29.53M | 25.12M |
Total Debt | 349K | 389K | 490K | 552K | 593K | 2.88M | 684K | 33.55M | 49.21M | 47.45M | 41.84M | 41.24M | 37.22M | 3.53M | 4.14M | 2.76M | 2.82M | 1.17M | 2.72M | 3.23M | 3.63M | 2.83M |
Book Value | 3.2M | 6.86M | 2.4M | 3.57M | 4.44M | -5.95M | 1.7M | -45.39M | -8.53M | -3.41M | 2.23M | 3.56M | 3.87M | 7.38M | 12.11M | 8.81M | 14.78M | 17.31M | 25.5M | 13.04M | 35.18M | -4.42M |
Book Value Per Share | 2.70 | 8.66 | 7.64 | 10.85 | 21.45 | -2.79 | 0.83 | -209.76 | -39.40 | -15.77 | 10.32 | 16.46 | 18.23 | 35.99 | 68.77 | 74.91 | 125.66 | 161.40 | 245.05 | 129.01 | 414.42 | -79.52 |
Common Stock | 6K | 6K | 39K | 39K | 37K | 262K | 257K | 27K | 27K | 27K | 27K | 27K | 27K | 26K | 26K | 15K | 287K | 287K | 13K | 260.22K | 223.54K | 207.53K |
Retained Earnings | -255.16M | -251.14M | -245.64M | -244.13M | -242.89M | -239.74M | -231.54M | -225.77M | -199.17M | -193.63M | -186.98M | -180.82M | -175.23M | -170.71M | -165.3M | -160.8M | -153.48M | -150.08M | -140.7M | -151.23M | -65.18M | -55.08M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a |
Shareholders Equity | 3.2M | 6.86M | 2.4M | 3.57M | 4.44M | -5.95M | 1.7M | -45.39M | -8.53M | -3.41M | 2.23M | 3.56M | 3.87M | 7.38M | 12.11M | 8.81M | 14.78M | 17.31M | 25.5M | 13.04M | 35.18M | -4.42M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.09M | 4.09M | n/a | 4.1M | n/a | 8K | 59K | 68K | 89K | 385K | 1M | 1M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ERNA